Virvio Company
Developer of a broadly-protective influenza therapeutic.
Founded Date:
2015-12-01
Technology:
Early Drug Development
Total Funding:
209000.0
Employee Number:
1-10
Headquarters:
Seattle, Washington, United States
Last Funding Date:
2016-02-15
Investors Number:
1.0
Last Funding Type:
Grant
Estimated Revenue:
Less than $1M
Industry:
Early Drug Development